Reports

Ideas That Generate Results

US Cancer Vaccine Market Outlook 2020

US Cancer Vaccine Market Outlook 2020

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Jul, 2015| No. of Pages : 130

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1200.00
CD-ROM Mail Delivery
US$ 1400.00
Hard Copy Mail Delivery
US$ 1400.00
Electronic Access - Multi-User License
US$ 2000.00

List of Figures:

Figure 3-1: Cancer Incidences (Million), 2008-2014
Figure 3-2: Cancer Mortality (‘000), 2008-2014
Figure 3-3: Incidences by Type of Cancer (%), 2014
Figure 3-4: States with Highest Cancer Incidences, 2014
Figure 4-1: Global - Cancer Vaccine Market (Billion US$), 2014-2020
Figure 4-2: Cancer Vaccine Market (Billion US$), 2014-2020
Figure 4-3: Share of US in Global Cancer Vaccine Market (2014)
Figure 4-4: Cancer Vaccine Market by Product Type (%), 2014
Figure 4-5: Provenge Market (Million US$), 2012-2014
Figure 4-6: Global - Gardasil Market (Million US$), 2012-2014
Figure 4-7: Gardasil Market (Million US$), 2012-2014
Figure 4-8: Share of US in Global Gardasil Sales (2014)
Figure 4-9: Global - Cervarix Market (Million US$), 2012-2014
Figure 4-10: Cervarix Market (Million US$), 20102-2014
Figure 4-11: Share of US in Global Cervarix sales (2014)
Figure 4-12: Global - Hepatitis B Vaccine Market (Billion US$), 2012-2014
Figure 4-13: Hepatitis B Vaccine Market (Million US$), 2012-2014
Figure 4-14: Global - Engerix-B and Twinrix Market (Million US$), 2012-2014
Figure 4-15: Engerix-B and Twinrix Market (Million US$), 2012-2014
Figure 4-16: Global - Recombivax Market (Million US$), 2012-2014
Figure 4-17: Recombivax Market (Million US$), 2010-2012
Figure 4-18: Global - Pediarix/Infanrix Market (Billion US$), 2012-2014
Figure 4-19: Pediarix/ Infanrix Market (Million US$), 2012-2014
Figure 5-1: Therapeutic Cancer Vaccines in Clinical Trials by Cancer Site (%), 2014

List of Tables:

Table 3-1: Top 10 Cancer Incidences in Males (2014)
Table 3-2: Top 10 Cancer Incidences in Females (2014)
Table 3-3: Top 10 Cancer Incidences in Children (Ages 0-14), (2014)
Table 4-1: Adverse Effects of Gardasil
Table 5-1: Cancers with High Linkage to Virus and Bacteria
Table 5-2: Prophylactic Cancer Vaccines in Clinical Trials
Table 5-3: Therapeutic Cancer Vaccines in Clinical Trials
Table 5-4: Prostate Cancer Therapeutic Vaccines in Phase-3 Clinical Trials
Table 5-5: Prostate Cancer Therapeutic Vaccines in Phase-2 Clinical Trials
Table 5-6: Prostate Cancer Therapeutic Vaccines in Phase-1 and 1/2 Clinical Trials
Table 5-7: Breast Cancer Therapeutic Vaccines in Phase-3 Clinical Trials
Table 5-8: Breast Cancer Therapeutic Vaccines in Phase-2 Clinical Trials
Table 5-9: Breast Cancer Therapeutic Vaccines in Phase-1 and 1/2 Clinical Trials
Table 5-10: Lung Cancer Therapeutic Vaccines in Phase-3 Clinical Trials
Table 5-11: Lung Cancer Therapeutic Vaccines in Phase-2 and 2/3 Clinical Trials
Table 5-12: Lung Cancer Therapeutic Vaccines in Phase-1 and 1/2 Clinical Trials
Table 5-13: Colorectal Cancer Therapeutic Vaccines in Phase-3 Clinical Trials
Table 5-14: Colorectal Cancer Therapeutic Vaccines in Phase-2 Clinical Trials
Table 5-15: Colorectal Cancer Therapeutic Vaccines in Phase-1 and 1/2 Clinical Trials
Table 7-1: Merck - Cancer Vaccines in Pipeline
Table 7-2: GlaxoSmithKline - Cancer Vaccines in Pipeline
Table 7-3: Bavarian Nordic - Cancer Vaccines in Pipeline
Table 7-4: Celldex Therapeutics - Cancer Vaccines in Pipeline
Table 7-5: KAEL-GemVax - Cancer Vaccines in Pipeline
Table 7-6: Galena Biopharma - Cancer Vaccines in Pipeline

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.